Testing Gene PilotLX With Latinx Cancer Patients
Recruiting
N/A
Interventional Study
Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 232 (estimated)
- Sponsor
- Fox Chase Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a randomized controlled trial designed to evaluate the efficacy of an electronic health decision support tool called Gene PilotLX to increase informed decision making regarding hereditary risk information from tumor genomic profiling (TGP) test among Latinx cancer patients recruited at four cancer centers.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Self-identified Latinx patients who:
1. diagnosed with solid tumor cancers
2. speak/read English or Spanish;
3. can provide informed consent.
Exclusion Criteria:
Patients with hematologic/liquid cancers (leukemia, lymphoma, multiple myeloma, etc.)
Contacts